Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry

Decline in private equity and venture capital deals in healthcare reflected in the decline of PEVC deals in pharma and biotech industry


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2014-04-30 07:08:02 - Private Equity and Venture Capital Investment in the Global Pharmaceutical and Biotechnology Industry - a new market research report on companiesandmarkets.com

The challenges posed by reducing margins, expiring patents, increasing compliance costs, and regulatory thrusts because of delayed approvals are forcing participants in the pharmaceutical and biotechnology industry to restructure and streamline strategies to cease the diminishing profitability and increase the returns from research and development (R&D). Though the returns from the pharmaceutical and biotechnology (pharma and biotech) industry have been on the decline compared to previous years, they are better compared to the performance of other industries.
Global decline in private equity and venture capital (PEVC) deals in healthcare (HC) is reflected in the decline of PEVC deals in the pharma and biotech industry. Venture capital (VC) deals in both the pharmaceutical and biotechnology sectors witnessed a decline in average

 

 

deal value over the years, with an increase in rounds of investment. The deal value analysis showed a preference for mid-sized deals in both private equity (PE) and VC investment. Geographic analysis revealed the United States represents the largest share of deals, and the sectorial preference of investors varied across geographies. The strong comeback of initial public offering (IPO) in 2013 sends a positive outlook for investment in the pharma and biotech ndustry.

Click for report details: www.companiesandmarkets.com/Market/Chemicals/Market-Research/Pri ..

Browse all Chemicals Market Research Reports www.companiesandmarkets.com/Market/Chemicals/Market-Research?aCo ..

Browse all Chemicals Company Profile Reports www.companiesandmarkets.com/Market/Chemicals/Company-Profile?aCo ..

Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com